
News in Brief April 4 – Colgate, Abilify and More
The U.S. Food and Drug Administration has issued a warning that says Abilify users may be able to attribute unnatural shopping sprees and binge eating to the medication.
The U.S. Food and Drug Administration has issued a warning that says Abilify users may be able to attribute unnatural shopping sprees and binge eating to the medication.
American Airlines has been hit with a proposed class action claiming that it illegally prevented its baggage handlers from collecting overtime.
Ferrari is facing a proposed class action claiming that it hid a defect that could lead to complete engine failure.
A look at today's leading stories. Class actions have been filed against Arm and Hammer and Toyota, while Whole Foods escapes a class action from PETA.
The New York Times has been hit with a proposed class action alleging a pattern of race, age and gender discrimination at one of the country's largest news outlets.
Whole Foods has been hit with a lawsuit claiming that its checkout scales measure weight differently than the scales in the produce department.
The U.S. Food and Drug Administration announced that it's reviewing a Danish study linking Pfizer's Diflucan yeast infection treatment to an increased risk of miscarriage
A proposed class action claimed that Kraft Heinz tricked customers into believing that its sauces were made in the United States.
Shoe and accessory retailer Cole Haan has been accused of not giving employees required breaks or proper overtime pay.
When is a bargain actually a bargain? There's a lot more to that question than you'd expect. Outlet stores across America have found themselves in legal hot water.